Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections

Journal of Infectious Diseases

Volumn 209, Issue 12, 2014, Pages 1900-1906

  Abravanel, Florence ^a,b,e   Lhomme, Sebastien ^a,b   Chapuy Regaud, Sabine ^a,b   Mansuy, Jean Michel ^b   Muscari, Fabrice ^d   Sallusto, Federico ^c   Rostaing, Lionel ^a,c   Kamar, Nassim ^a,c   Izopet, Jacques ^a,b  

^a University of Toulouse III   (United States)

^b National Reference Center for Hepatitis E Laboratoire de virologie Hôpital Purpan   (United States)

^c Service de Néphrologie Dialyse et Transplantation multi organe   (United States)

^d CHU RANGUEIL   (France)

^e CHU PURPAN   (France)

Author keywords

Hepatitis E virus; incidence; reinfection; solid organ transplant recipients

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CORRELATIONAL STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS E; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PATIENT MONITORING; PRIORITY JOURNAL; RECIPIENT; REINFECTION; SEROPREVALENCE; SOLID ORGAN RECIPIENT;

HEPATITIS E VIRUS; INCIDENCE; REINFECTION; SOLID ORGAN TRANSPLANT RECIPIENTS;

CHRONIC DISEASE; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RNA, VIRAL;

EID: 84901800985     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu032     Document Type: Article

References (38)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012; 379:2477-88.
2. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003; 10:61-9. (Pubitemid 36237814)
3. Hamid SS, Atiq M, Shehzad F, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002; 36:474-8. (Pubitemid 34810369)
4. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8:698-709.
5. Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14:547-53. (Pubitemid 351524412)
6. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358:811-7. (Pubitemid 351281642)
7. le Coutre P, Meisel H, Hofmann J, et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58:699-702.
8. Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009; 150:430-1.
9. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361:1025-7.
10. Kenfak-Foguena A, Schoni-Affolter F, Burgisser P, et al. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011; 17:1074-8.
11. Kamar N, Rostaing L, Legrand-Abravanel F, Izopet J. How should hepatitis E virus infection be defined in organ-transplant recipients? Am J Transplant 2013; 13:1935-6.
12. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358:859-60. (Pubitemid 351281667)
13. Kamar N, Mansuy JM, Cointault O, et al. Hepatitis E virus-related cirrhosis in kidney-and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8:1744-8.
14. Huang S, Zhang X, Jiang H, et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS One 2010; 5:e13560.
15. Baylis SA, Hanschmann KM, Blumel J, Nubling CM. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011; 49:1234-9.
16. Drobeniuc J, Meng J, Reuter G, et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010; 51:e24-7.
17. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82:799-805.
18. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202:835-44.
19. Khuroo MS, Kamili S, Dar MY, Moecklii R, Jameel S. Hepatitis E and long-term antibody status. Lancet 1993; 341:1355.
20. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 1994; 91:10198-202. (Pubitemid 24311976)
21. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356:895-903. (Pubitemid 46339908)
22. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 2008; 80:95-101. (Pubitemid 350220094)
23. Bigaillon C, Tesse S, Lagathu G, Nicand E. Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J Virol Methods 2010; 164:127-30.
24. Seriwatana J, Shrestha MP, Scott RM, et al. Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin Diagn Lab Immunol 2002; 9:1072-8. (Pubitemid 34988478)
25. Abravanel F, Sandres-Saune K, Lhomme S, Dubois M, Mansuy JM, Izopet J. Genotype 3 diversity and quantification of hepatitis e virus RNA. J Clin Microbiol 2012; 50:897-902.
26. Legrand-Abravanel F, Mansuy JM, Dubois M, et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 2009; 15:110-4.
27. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011; 17:30-7.
28. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E Virus Antibodies in Blood Donors, France. Emerg Infect Dis 2011; 17:2309-12.
29. Abravanel F, Mansuy JM, Huynh A, et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012; 54:152-5.
30. Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, Brown D. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009; 44:272-6.
31. Faramawi MF, Johnson E, Chen S, Pannala PR. The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol Infect 2011; 139:1145-50.
32. Li RC, Ge SX, Li YP, et al. Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 2006; 12:1682-8.
33. Suneetha PV, Pischke S, Schlaphoff V, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012; 55:695-708.
34. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140:1481-9.
35. Zhang J, Li SW, Wu T, Zhao Q, Ng MH, Xia NS. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity. Rev Med Virol 2012; 5:339-49.
36. Huang W, Zhang H, Harrison TJ, Lang S, Huang G, Wang Y. Crossprotection of hepatitis E virus genotypes 1 and 4 in rhesus macaques. J Med Virol 2008; 80:824-32. (Pubitemid 351500030)
37. Takahashi M, Tanaka T, Takahashi H, et al. Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol 2010; 48:1112-25.
38. Versluis J, Pas SD, Agteresch HJ, et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 2013; 122:1079-86.